Navigation Links
Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention
Date:6/4/2008

The state's presence is a prelude to the 2009 convention to be held in

Georgia

ATLANTA, June 4 /PRNewswire/ -- Georgia will showcase its bioscience leadership at the 2008 Bio international convention on June 17 -- 20, in San Diego, Calif. Governor Perdue will deliver remarks on June 19 and meet with state and business leaders during the convention.

"As one of the fastest-growing industries in the nation, the biosciences sector is a strategic priority for Georgia and a driving force behind our future growth," said Governor Perdue. "Our leadership in university-based research, strong biosciences talent, effective public-private partnerships and ease of access to international capital markets truly position Georgia as the crossroads of global health."

Georgia will host a 3,300 square-foot pavilion, which includes 28 exhibitors representing Georgia's wide breadth of bioscience companies, research institutions and state agencies. A sample of exhibitors:

Companies

1. Altea Therapeutics*

2. Atlanta Center for Medical Research

3. Celtaxsys

4. ICON Medical Corp.

5. Optima Chemical

6. St Joseph's Translational Research Institute

7. Sciele Pharma

8. Solvay Pharmaceuticals

9. UCB, Inc.*

10. Zygogen

Research Institutions

1. Emory*

2. Georgia Tech

3. Georgia State

4. University Medical College of Georgia

5. University of Georgia

State Agencies & Other

1. Georgia Quick Start

2. Georgia Department of Economic Development

3. Centers for Disease Control and Prevention

4. Agriculture Innovation Center

5. Life Sciences Innovation Center

6. Augusta Life Sciences

7. Innovation Crescent

8. Georgia Research Alliance*

9. Georgia BIO*

* Spokesperson available.

In addition to the pavilion, researchers from Georgia's pre-eminent institutions, including the CDC, Emory University and the University of Georgia, along with representatives from companies, will discuss key global health issues. Panels confirmed to date include:

1. Influenza Research and Surveillance: Preparing for the Next Pandemic

(June 17, 8:15 a.m. to 9:45 a.m., Room 29A)

a. Team Lead, Molecular Virology & Vaccines Branch, Influenza

Division, Centers for Disease Control and Prevention.

2. Lurking in the Shadows: Are You Prepared for the Next Threat? (June

17, 1:30 p.m. to 3 p.m., Room 27AB)

a. Stephen A. Morse, PhD, Chair, Associate Director for Science,

Division of Bioterrorism, Preparedness and Response, Centers for

Disease Control and Prevention.

b. Ralph A. Tripp, PhD, Chair, Professor & GRA Eminent Scholar,

Dept. of Infectious Diseases, College of Veterinary Medicine,

University of Georgia.

c. Rich Dluhy, PhD, Director, Nanoscale Science and Engineering

Center, University of Georgia.

3. Antibiotic-Resistant Staph Infections: Challenges and Progress (June

17, 4 p.m. to 5:30 p.m., Room 28 CD)

a. Walter A. Orenstein, MD -- Chair, Professor of Medicine and

Pediatrics; Associate Director, Emory Vaccine Center, Emory

University School of Medicine.

b. Roberta B. Carey, PhD, Chief, Clinical and Environmental

Microbiology Branch, Division of Healthcare Quality Promotion,

Centers for Disease Control and Prevention.

c. Henry M. Blumberg, MD, Professor of Medicine and Program

Director, Division of Infectious Diseases, Emory University

School of Medicine; Hospital Epidemiologist, Grady Memorial

Hospital, Emory University School of Medicine.

d. Joseph M. Patti, PhD, CSO, Senior Vice President Research &

Development, Inhibitex, Inc.

4. Diabetes Treatment: Advances in Cell-Based Therapies (June 17, 8:15

a.m. to 9:45 a.m., Room 29 CD)

a. Collin J. Weber, MD -- Chair, Professor of Surgery, Emory

University School of Medicine.

5. Improved Pharmaceutical Manufacturing Through Controlled Enzyme

Evolution (June 19, 4 p.m. to 5:30 p.m., Room 28 AB)

a. Andreas Bommarius, PhD -- Chair, Professor, School of Chemical &

Biomolecular Engineering, Georgia Institute of Technology.

About Georgia's Bioscience Industry

With strong talent, a spirit of collaboration and access to the world, Georgia is at the crossroads of global health. Georgia is home to the CDC, CARE, the American Cancer Society, the Arthritis Foundation and 270 bioscience companies. The state offers robust public-private partnerships in bioscience, including the Georgia Research Alliance, through which the State's six research universities collaborate to create, improve and grow science -- and technology-based companies. Additionally, Georgia boasts a strong talent pool, with the nation's highest growth in market share of college-educated 25-to-34 year-olds and one of the largest state university systems in the country, graduating 44,000 students each year. For more information on Georgia's bioscience industry and its presence at BIO 2008 and 2009, visit http://www.georgiabiosciences.com .


'/>"/>
SOURCE Georgia Department of Economic Development
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Piedmont Heart Institute Welcomes Cardiology of Georgia
2. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
3. Siemens Showcases New ACUSON S2000 Ultrasound System, as Well as Worlds First Pocket Ultrasound System
4. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
5. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
6. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
7. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
8. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
9. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
10. LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics
11. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Charlotte, NC (PRWEB) , ... February 10, 2016 ... ... highly anticipated expansion to their comprehensive training and support program, Sonalinkā„¢ remote monitoring. ... Sonablate® HIFU procedures performed on Friday, February 5th, connecting Dr. Samuel Peretsman to ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... current winner of the Highest Overall Customer Rating Award from Circuits Assembly , ... business units across the USA, Canada, Mexico and China. , The EMS provider, ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... on its free and validated Electronic Data Capture (EDC) system ClinCaptureand its new ... Clinical Trials West Coast 2016 Conference in San Mateo, California on February 10th ...
(Date:2/9/2016)...  DNAtrix, a clinical stage, biotechnology company ... its lead product, DNX-2401, has been designated ... medicinal product for the treatment of glioma. ... approximately 25,000 people a year in the ... --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
Breaking Biology Technology:
(Date:1/13/2016)... DUBLIN , January 13, 2016 ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the ... & Identification Market - Estimation & ...
(Date:1/11/2016)... 11, 2016  higi, the leading retail and ... locations, web and mobile, today announced it has ... existing investors. --> ... further innovate higi,s health platform – its network ... – including expanding services and programs to retail ...
(Date:1/8/2016)... January 8, 2016 NXTD ), ... WorldVentures ® , a privately held leading direct seller ... Inc. 5000 fastest-growing company announced that on December ... $2 million in Nxt-ID to develop a proprietary new ... Wocket ® , a unique smart wallet that serves ...
Breaking Biology News(10 mins):